Month: July 2026

Recombinant Human Albumin in Weekend-Free hiPSC Culture – ISSCR Poster

By

Recombinant Human Albumin Supports Weekend-Free hiPSC Culture and Protein-Free Cardiac Differentiation Presented at ISSCR by Davi Lyra-Leite (BMEM Bio), Mark Stathos and Elliott Renft (InVitria), and Paul W. Burridge (Northwestern University Feinberg School of Medicine). The Problem Weekend-free hiPSC media change schedules save labor, but they have been reported to reduce subsequent differentiation efficiency. This …

Evonik Interview: How Recombinant Albumin De-Risks Cell Therapy Manufacturing

By

Introduction Our partner Evonik has published a detailed interview featuring InVitria’s Director of Business Development, Jake Hanks. The discussion focuses on how recombinant human serum albumin helps biopharma manufacturers reduce risks in cell therapy production through greater consistency, purity, and supply security. Full Interview Link Read the complete Evonik interview Partnership Overview Evonik distributes InVitria’s …